Grace Therapeutics (GRCE) Other Non-Current Assets (2017 - 2023)
Grace Therapeutics (GRCE) reported Other Assets of $23,000 for fiscal Q3 2024 (quarter ended Dec 31, 2023), down 93.5% from $352,000 a year earlier and down 51.1% from the prior quarter.
Grace Therapeutics (GRCE) Other Non-Current Assets (2017 - 2023) Analysis & Trends
At the end of FY2023 (ended Mar 31, 2023), Grace Therapeutics posted Other Assets of $463,000, up 31.5% from FY2022.
- Other Assets has a five-year compound annual growth rate of -13.2% (FY2018 to FY2023).
- By fiscal year, Other Assets came in at $352,000 in FY2022 (-54.2%), $768,000 in FY2021 (+62.4%), $473,000 in FY2020 (-46.4%) and $883,000 in FY2019 (-6.3%).
- The fiscal Q3 2024 figure ranks as the lowest quarterly Other Assets since fiscal Q3 2019.
- Year over year, Other Assets has now declined in each of the last three quarters, with an average decline of 48.3% over the last eight quarters.
- The high point for year-over-year Other Assets in five years was fiscal Q3 2020 (growth of 626.1%); the low point was fiscal Q3 2024 (a decline of 93.5%).
- Per Business Quant data, the three fiscal quarters before Q3 2024 came in at $47,000 (Q2 2024), $71,000 (Q1 2024) and $463,000 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Mar 31, 2023 | 463,000.00 |
| Dec 31, 2022 | 352,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Jun 30, 2022 | 352,000.00 |
| Mar 31, 2022 | 352,000.00 |
| Dec 31, 2021 | 587,000.00 |
| Sep 30, 2021 | 764,000.00 |
| Jun 30, 2021 | 392,000.00 |
| Mar 31, 2021 | 768,000.00 |
| Dec 31, 2020 | 712,000.00 |
| Sep 30, 2020 | 680,000.00 |
| Jun 30, 2020 | 883,000.00 |
| Mar 31, 2020 | 473,000.00 |
| Dec 31, 2019 | 138,584.76 |
| Sep 30, 2019 | 49,112.20 |
| Jun 30, 2019 | 49,639.92 |
| Mar 31, 2019 | 877,852.62 |
Grace Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();